|
Accession # |
Unigene # |
Gene Symbol |
Name |
Sequence |
MEDLINE |
| NM_024148.1 |
Rn.5949 |
Apex1 |
Apurinic/apyrimidinic endonuclease 1 |
5'-GUCUGGUAAGACUGGAGUACC-3' |
REF |
| NM_017059.1 |
Rn.10668 |
Bax |
Bcl2-associated X protein |
5'-UUGGAGAUGAACUGGACAAUU-3' |
REF |
| NM_017059.1 |
Rn.10668 |
Bax |
Bcl2-associated X protein |
5'-CUG GAC AAU AAU AUG GAG CUU-3' |
REF |
| NM_023979.1 |
Rn.64522 |
Apaf1 |
Apoptotic protease activating factor 1 |
5'-AGA ACU UUG UGC UUU AAU GUU-3' |
REF |
| NM_023979.1 |
Rn.64522 |
Apaf1 |
Apoptotic protease activating factor 1 |
5'-UAU AGG CAU AUA CUG GAU GUU-3' |
REF |
| NM_021835.2 |
Rn.93714 |
Jun |
V-jun sarcoma virus 17 oncogene homolog (avian) |
5'-AGU GAA AAC CUU GAA AGC GUU-3' |
REF |
| NM_021835.2 |
Rn.93714 |
Jun |
V-jun sarcoma virus 17 oncogene homolog (avian) |
5'-AGU CAU GAA CCA CGU UAA CUU-3' |
REF |
| NM_012655.1 |
Rn.44609 |
Sp1 |
Sp1 transcription factor |
AATGAGAACAGCAACAACTCC |
REF |
| XM_230974.2 |
Rn.102138 |
Sp3 |
Sp3 transcription factor |
AAGTTCTCAGACAATGACTGC |
REF |
| NM_133551.1 |
Rn.10162 |
Pla2g4a |
Phospholipase A2, group IVA (cytosolic, calcium-dependent) |
5'-TCGAGACAGTAGTGGTTCTACGTGCCgagtactg
GGCACGTAGAACCACTACTGTTTTTT-3'
|
REF |
| NM_001003959.1 |
Rn.117353 |
Dnmt3b |
DNA methyltransferase 3B |
5'-AGAUGACAGGUGCCCAGAGUU-3' |
REF |
| NM_019335.1 |
Rn.10022 |
Prkr |
Protein kinase, interferon-inducible double stranded
RNA dependent |
5-GGUAGAUCAAAGCAGGAGGTT-3' |
REF |
| NM_053622.1 |
Rn.10474 |
Pom121 |
Nuclear pore membrane glycoprotein 121 kD |
5'-AACGGAGUCCCUGCUGCAUUUdTdT-3' |
REF |
| NM_053622.1 |
Rn.10474 |
Pom121 |
Nuclear pore membrane glycoprotein 121 kD |
5'-AACCAUGUCACCAGUCCAGUUdTdT-3' |
REF |
| NM_053622.1 |
Rn.10474 |
Pom121 |
Nuclear pore membrane glycoprotein 121 kD |
5'-AAGCCUGUGUUUGGCUUUGGAdTdT-3' |
REF |
| NM_131907.2 |
Rn.5805 |
Atp2c1 |
ATPase, Ca++-sequestering |
5'- AACCATTATGGAAGAAGTACATT-3' |
REF |
| NM_031337.1 |
Rn.22706 |
Siat9 |
Sialyltransferase 9 |
5'-GGGUUAUUCUGAACAUGUUtt-3' |
REF |
| NM_031010.2 |
Rn.11318 |
Alox15 |
Arachidonate 12-lipoxygenase |
5'-GCAACTGGATTTCTGTGAAGG-3' |
REF |
| NM_031010.2 |
Rn.11318 |
Alox15 |
Arachidonate 12-lipoxygenase |
5'-GAAGCGGATTTCTTCCTTCTG-3' |
REF |
| NM_031556.1 |
Rn.22518 |
Cav |
Caveolin |
5'-AAGGAGATCGACCTGGTCAAC-3' |
REF |
| NM_031556.1 |
Rn.22518 |
Cav |
Caveolin |
5'-AAGGGACACACAGTTTTGACG-3' |
REF |
| XM_232106.2 |
Rn.117974 |
Dok-1 |
Docking protein 1 (predicted) |
5'-GAACTACACAAATTCAGCCAGGCGTA
TCATCCGGTGTTTCGTCCTTTCCACAAG-3'
|
REF |
| NM_133307.1 |
Rn.98279 |
Prkcd |
Protein kinase C, delta |
5'- AAAAGGCAAATTCACAAACAGCCTGTCTC -3' |
REF |
| NM_133307.1 |
Rn.98279 |
Prkcd |
Protein kinase C, delta |
5'- AAGTTCTCCGAAGTGTGAGAACCTGTCTC -3' |
REF |
| NM_012637.1 |
Rn.11317 |
Ptpn1 |
Protein tyrosine phosphatase, non-receptor type
1 |
5'-AAGCTGACACTGATCTCTGAA-3' |
REF |
| NM_017212 |
Rn.2455 |
Mapt |
Microtubule-associated protein tau |
5'-CCAGGAGTTTGACACAATG-3' |
REF |
| NM_013156 |
Rn.1294 |
CTSL |
Cathepsin L |
5'-GGACAGAUGUUCCUUAAGATT-3' |
REF |
| NM_012576.1 |
Rn.90070 |
Nr3c1 |
Nuclear receptor subfamily 3, group C, member
1 |
5'-GGCCAAGGGAGGGGGAGCGTA-3' |
REF |
| NM_013131.1 |
Rn.9678 |
Nr3c2 |
Nuclear receptor subfamily 3, group C, member
2 |
5'-GGCGCTGGAGTCAAGTGTCTC-3' |
REF |
| NM_031659 |
Rn.10039 |
Tgm1 |
Transglutaminase 1 |
5'-AUGCAGCUGGAGAUGGCACdTdT-3' |
REF |
| NM_019275 |
Rn.9774 |
Madh4 |
MAD homolog 4 |
5'-AAUACACCGACAAGCAAUGACdTdT-3' |
REF |
| NM_031132 |
Rn.9954 |
Tgfbr2 |
Transforming growth factor, beta receptor II |
5'-AAAGUCGGUUAACAGCGAUCUdTdT-3' |
REF |
| NM_144741 |
Rn.16746 |
Retn |
Resistin |
5'-CCTTTCATTTCTCCTCCTT-3' |
REF |
| NM_144741 |
Rn.16746 |
Retn |
Resistin |
5'-AGCTGCTCCTGTGGCTCTG-3' |
REF |
| NM_144741 |
Rn.16746 |
Retn |
Resistin |
5'-GCCTCCTGCCCAGAAGGCA-3' |
REF |
| NM_012614 |
Rn.9714 |
Npy |
Neuropeptide Y |
5'-UGAGAGAAAGCACAGAAA-3' |
REF |
| NM_021597 |
Rn.35512 |
Eif2c2 |
GERp95 |
5'-UGGACAUCCCCAAAAUUGA-3' |
REF |
| NM_012547 |
Rn.87299 |
Drd2 |
Dopamine receptor 2 |
5'-CCCCAUCAUCUACACCACA-3' |
REF |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|